SCHEMBL16475652

SCHEMBL16475652

C=Cc1ccc(OC)cc1O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRIM24 O15164 1/20 0.67
TYR P14679 1/20 0.67
TRIM33 Q9UPN9 1/20 0.67
CYP1A1 P04798 3/20 0.59
CYP1B1 Q16678 3/20 0.59
CYP1A2 P05177 2/20 0.59
AR P10275 1/20 0.54
ERN1 O75460 1/20 0.52
MAPT P10636 5/20 0.49
ALDH1A1 P00352 4/20 0.49
GAA P10253 2/20 0.49
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
GSK3B P49841 1/20 0.48
MAPK1 P28482 2/20 0.47
CYP3A4 P08684 1/20 0.47
HPGD P15428 1/20 0.47
HSD17B10 Q99714 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14613174 0.84 ERN1 (0.67) TRIM24TYRTRIM33CYP1A1CYP1B1
SCHEMBL18649676 0.82 TYR (0.50) TRIM24TYRTRIM33CYP1A1CYP1B1
SCHEMBL3210928 0.82 TRIM24 (0.69) TRIM24TYRTRIM33CYP1A1CYP1B1
SCHEMBL9065566 0.81 CYP1A2 (0.52) TRIM24TYRTRIM33CYP1A1CYP1B1
SCHEMBL30567454 0.81 CYP1A2 (0.52) TRIM24TYRTRIM33CYP1A1CYP1B1
SCHEMBL28351242 0.80 MAPT (0.47) TRIM24TYRTRIM33CYP1A1CYP1B1
SCHEMBL28348298 0.80 TRIM24 (0.45) TRIM24TYRTRIM33CYP1A1CYP1B1
SCHEMBL133876 0.80 TYR (1.00) TRIM24TYRTRIM33CYP1A1CYP1B1
SCHEMBL28351485 0.80 TYR (0.48) TRIM24TYRTRIM33CYP1A1CYP1B1
SCHEMBL10399237 0.80 TRIM24 (0.67) TRIM24TYRTRIM33CYP1A1CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140107166-A1 HISTONE DEACETYLASE INHIBITORS AND METHODS OF USE THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2014-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140107166-A1 HISTONE DEACETYLASE INHIBITORS AND METHODS OF USE THEREOF HDAC1, HDAC5, HDAC11 TRIM24 2504/4885TYR 978/4885TRIM33 2111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.